Naturex SA has acquired Swedish Oat Fiber AB
November 2017 — Naturex SA, the global leader in specialty plant-based natural ingredients, has acquired Swedish Oat Fiber AB, a specialized manufacturer of oat dietary fibers, oat oils and oat proteins. Financial details have not been disclosed.
Naturex sources, manufactures and markets natural specialty ingredients for the food, healthcare and cosmetic industries. Headquartered in Avignon, France, the group has experienced steadily increasing growth throughout the last 25 years. Naturex employs 1,700 people worldwide and had revenues of US$437 million in 2016.
Swedish Oat Fiber is a manufacturer with a key international position as a producer of oat beta-glucans dietary fibers, oat oils and oat proteins for the food industry, nutraceutical, cosmetic and animal feed applications. The company has 25 employees and an annual turnover of US$13.2 million.
Our role in the transaction
Oaklins' teams in France and Sweden identified potential targets and advised the buyer on this transaction. This is another example of the strength of Oaklins' teams working together.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more